Terlipressin Acetate ukuba inaliti

1mg/vial Amandla

Isalathiso: Kunyango lwe-esophageal variceal blood.

Ukusetyenziswa kweklinikhi: inaliti ye-intravenous.

I-Terlipress kwi-acetate EVER I-Pharma 0.2 mg/ml isisombululo sokutofa iqulethe isithako esisebenzayo i-terlipress in, eyi-hormone yokwenziwa kwe-pituitary (le hormone idla ngokuveliswa yi-pituitary gland efumaneka kwingqondo).

Uya kunikwa ngokutofwa emithanjeni.

I-Terlipress kwi-acetate EVER Pharma 0.2 mg/ml isisombululo sokutofa sisetyenziselwa unyango lwe:

• ukopha kwimithambo yombhobho wokutya okhokelela esiswini sakho (okubizwa ngokuba yi-esophageal varices).

• unyango olungxamisekileyo lohlobo lwe-1 hepatorenal syndrome (ukungaphumeleli kwe-renal ngokukhawuleza) kwizigulane ezine-cirrhosis yesibindi (i-scarring yesibindi) kunye ne-ascites (i-dropsy yesisu).

Eli yeza liya kusoloko linikezelwa kuwe ngugqirha emthanjeni wakho. Ugqirha uya kuthatha isigqibo malunga neyona dose efanelekileyo kuwe kunye nentliziyo yakho kunye nokujikeleza kwegazi kuya kuhlolwa ngokuqhubekayo ngexesha lokutofa. Nceda ubuze ugqirha wakho ngolwazi oluthe kratya malunga nokusetyenziswa kwayo.

Sebenzisa kubantu abadala

1. Ulawulo lwexesha elifutshane lokuphuma kwegazi kwi-esophageal varices

Ekuqaleni i-1-2 mg terlipress kwi-acetate (i-5-10 ml ye-Terlipress kwi-acetate EVER Pharma 0.2 mg / ml isisombululo se-injection) inikezelwa nge-injection kwi-vein yakho. Idosi yakho iya kuxhomekeka kubunzima bomzimba wakho.

Emva kwesitofu sokuqala, umthamo wakho unokuncitshiswa ukuya kwi-1 mg terlipress kwi-acetate (5 ml) rhoqo kwi-4 kwiiyure ze-6.

2. Uhlobo lwe-1 hepatorenal syndrome

I-dose eqhelekileyo yi-1 mg terlipress kwi-acetate nganye iiyure ze-6 ubuncinane iintsuku ze-3. Ukuba ukuncipha kwe-serum creatinine kungaphantsi kwama-30% emva kweentsuku ezi-3 zonyango ugqirha wakho kufuneka acinge ngokuphinda idosi kwi-2 mg rhoqo kwiiyure ezi-6.

Ukuba akukho mpendulo kwi-Terlipress kwi-acetate EVER Pharma 0.2 mg / ml isisombululo se-injection okanye kwizigulane ezinempendulo epheleleyo, unyango nge-Terlipress kwi-acetate EVER Pharma 0.2 mg / ml isisombululo se-injection kufuneka siphazamiseke.

Xa kubonwa ukuncipha kwe-serum creatinine, unyango nge-Terlipress kwi-acetate EVER Pharma 0.2 mg/ml isisombululo sokutofa kufuneka sigcinwe ukuya kutsho kwiintsuku ezili-14.

Sebenzisa kubantu abadala

Ukuba ungaphezu kweminyaka engama-70 ubudala thetha nogqirha wakho ngaphambi kokuba ufumane i-Terlipress kwi-acetate EVER Pharma 0.2 mg/ml isisombululo senaliti.

Sebenzisa kwizigulane ezineengxaki zezintso

I-Terlipress kwi-acetate EVER I-Pharma I-0.2 mg / ml isisombululo se-injection kufuneka isetyenziswe ngokuqaphela kwizigulane ezinokukhubazeka kwexesha elide.

Sebenzisa kwizigulane ezineengxaki zesibindi

Akukho ukulungiswa kwedosi efunekayo kwizigulane ezinokuhluleka kwesibindi.

Sebenzisa kubantwana nakwishumi elivisayo

I-Terlipress kwi-acetate EVER Pharma I-0.2 mg / ml isisombululo se-injection ayikhuthazwa ukuba isetyenziswe kubantwana nakwishumi elivisayo ngenxa yokungabikho kwamava aneleyo.

Ubude bexesha lonyango

Ukusetyenziswa kweli yeza kukhawulelwe kwii-2 - iintsuku ze-3 zokulawula ixesha elifutshane lokuphuma kwegazi kwi-esophageal varice kunye nobuninzi beentsuku ze-14 zonyango lwe-1 ye-hepatorenal syndrome, kuxhomekeke kwikhosi yemeko yakho.